A step forward in the evidence-based treatment of opportunist mycobacteria

Thorax. 2001 Mar;56(3):163. doi: 10.1136/thorax.56.3.163.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibiotics, Antitubercular / therapeutic use
  • Ethambutol / therapeutic use
  • Evidence-Based Medicine
  • Humans
  • Mycobacterium Infections / complications
  • Mycobacterium Infections / drug therapy*
  • Opportunistic Infections / complications
  • Opportunistic Infections / drug therapy*
  • Practice Guidelines as Topic
  • Rifampin / therapeutic use
  • United Kingdom

Substances

  • Antibiotics, Antitubercular
  • Ethambutol
  • Rifampin